These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6229678)

  • 41. The effects of cyclo(leucyl-glycyl) on nigrostriatal dopaminergic supersensitivity--inhibition of apomorphine-induced climbing.
    Fields JZ; Lee JM; Gordon JH; Wichlinski LJ; Ritzmann RF
    Neuropeptides; 1990 Aug; 16(4):207-11. PubMed ID: 2274115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cyclo(Leu-Gly) on reserpine-induced hypomotility and increases in cortical beta-adrenergic receptors.
    Klein E; Lerer B; Newman M; Belmaker RH; Bhargava HN
    Psychopharmacology (Berl); 1984; 83(1):76-8. PubMed ID: 6146157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ethanol administration of striatal D1 and D2 dopamine receptors.
    Hruska RE
    J Neurochem; 1988 Jun; 50(6):1929-33. PubMed ID: 2967351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390.
    De Montis GM; Devoto P; Meloni D; Porcella A; Saba P; Tagliamonte A
    J Neurosci Res; 1989 Oct; 24(2):286-92. PubMed ID: 2531233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine.
    Gomaa AA; Mohamed LH; Ahmed HN
    Eur J Pharmacol; 1989 Nov; 170(3):129-35. PubMed ID: 2620694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M; Dubois A; Benavidès J; Scatton B
    Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of dopaminergic mechanisms in mediating the central behavioral effects of morphine in rodents.
    Feigenbaum J; Yanai J
    Neuropsychobiology; 1984; 11(2):98-105. PubMed ID: 6090975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of peptides on tolerance to the cataleptic and hypothermic effects of morphine in the rat.
    Bhargava HN
    Neuropharmacology; 1981 Apr; 20(4):385-90. PubMed ID: 6117032
    [No Abstract]   [Full Text] [Related]  

  • 51. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS; Joyce JN
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ; Marshall JF
    Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Movement initiation characteristics in young adult rats in relation to the high- and low-affinity agonist states of the striatal D2 dopamine receptor.
    Wilcox RE; Mudie E; Mayfield D; Young RK; Spirduso WW
    Brain Res; 1988 Mar; 443(1-2):190-8. PubMed ID: 2965957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
    Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
    Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain.
    Kovács GL; Horváth Z; Sarnyai Z; Faludi M; Telegdy G
    Neuropharmacology; 1985 May; 24(5):413-9. PubMed ID: 2991800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.